Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jan 8:14:1497506.
doi: 10.3389/fonc.2024.1497506. eCollection 2024.

Case report: Illustrating associated malignancies in Paget's disease using contrast-enhanced mammography

Affiliations
Case Reports

Case report: Illustrating associated malignancies in Paget's disease using contrast-enhanced mammography

Luciano Mariano et al. Front Oncol. .

Abstract

Introduction: The following presentation explores the diagnostic potential of Contrast-Enhanced Mammography (CEM) in evaluating and managing Paget's Disease (PD) of the breast, particularly as an alternative or complementary tool to Magnetic Resonance Imaging (MRI) in cases where MRI is contraindicated or inconclusive.

Clinical cases: Two clinical cases of PD diagnosed at our Breast Imaging Division between January and May 2024 were analyzed using CEM. These cases involved imaging techniques, including Digital Mammography (DM), Breast Ultrasound (US), MRI and CEM, alongside histopathological confirmation through nipple-areolar complex (NAC) punch biopsies. CEM identified disease extensions and NAC involvement that was not evident in conventional imaging in both cases. CEM findings influenced surgical decisions, leading to total mastectomies with reconstruction instead of conservative approaches. The cases highlighted CEM's sensitivity and ability to delineate the disease extent comparable to MRI.

Discussion and conclusions: PD often presents diagnostic challenges due to frequent associations with underlying malignancies that are undetectable by standard imaging. While MRI is the gold standard, its limitations, such as costs, contraindications, and false positives, warrant alternative methods. CEM demonstrated utility in diagnosing and staging PD, offering benefits in patient acceptability, cost, and sensitivity comparable to MRI. CEM is a promising diagnostic and planning tool for PD management, especially in MRI-infeasible cases. More extensive multicentric studies will be needed to validate CEM's role in this context. CEM could enhance PD diagnostic workflows and treatment strategies, significantly impacting clinical outcomes.

Keywords: CEM; Paget carcinoma; breast cancer; breast imaging; contrast enhanced mammography.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Cranio-caudal (A) and Medio-lateral-oblique (B) DM views of the left breast show suspicious fine and pleomorphic microcalcifications from the upper-outer quadrant to the outer equatorial region (arrows) corresponding to ectasia ductal structures with multiple contextual hyperechogenic spots on US (C). The recombined medio-lateral-oblique CEM images (D, E) show, in addition to non-mass-like enhancement in the upper quadrants of the left breast (with a post-biopsy clip inside, E), a contrastographic impregnation of the ipsilateral NAC (arrows), highlighted in the focused magnification (F).
Figure 2
Figure 2
A DCE-MRI subtraction image (A) shows an enhancement of the left nipple with a non-mass-like enhancement in the outer quadrants (arrow). The 2D and recombined medio-lateral CEM images (B, C) confirm a later inhomogeneous non-mass-like enhancement in the outer quadrants of the left breast (arrow).
Figure 3
Figure 3
CEM-biopsy: 2D magnification and recombined focus (A, B) of the enhancement target in the outer quadrant of the left breast (arrow), where a vacuum-assisted biopsy was performed, followed by the clip placement (C, arrow).

Similar articles

References

    1. Mariano L, Nicosia L, Pupo D, Olivieri AM, Scolari S, Pesapane F, et al. . A pictorial exploration of mammary paget disease: insights and perspectives. Cancers (Basel). (2023) 15:5276. doi: 10.3390/cancers15215276 - DOI - PMC - PubMed
    1. Ashikari R, Park K, Huvos AG, Urban JA. Paget’s disease of the breast. Cancer. (1970) 26:680–5. doi: 10.1002/1097-0142(197009)26:3<680::AID-CNCR2820260329>3.0.CO;2-P - DOI - PubMed
    1. Mendez-Fernandez MA, Henly WS, Geis RC, Schoen FJ, Hausner RJ. Paget’s disease of the breast after subcutaneous mastectomy and reconstruction with a silicone prosthesis. Plast Reconstr Surg. (1980) 5:683–5. doi: 10.1097/00006534-198005000-00026 - DOI - PubMed
    1. Morrogh M, Morris EA, Liberman L, Van Zee K, Cody HS, 3rd, King TA. MRI identifies otherwise occult disease in select patients with Paget disease of the nipple. J Am Coll Surg. (2008) 206:316–21. doi: 10.1016/j.jamcollsurg.2007.07.046 - DOI - PubMed
    1. Echevarria JJ, Lopez-Ruiz JA, Martin D, Imaz I, Martin M. Usefulness of MRI in detecting occult breast cancer associated with Paget’s disease of the nipple-areolar complex. Br J Radiol. (2004) 77:1036–9. doi: 10.1259/bjr/94607773 - DOI - PubMed

Publication types

LinkOut - more resources